70 related articles for article (PubMed ID: 35667784)
1. Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma.
Tsai YC; Schlaepfer T; Ignatova D; Chang YT; Valaperti A; Amarov B; Blanchard G; Pehr K; Vonow-Eisenring M; Urosevic-Maiwald M; Hoetzenecker W; Pascolo S; Iselin C; Fassnacht C; Dimitriou F; Bobrowicz M; Guenova E
Br J Dermatol; 2023 Oct; 189(5):603-611. PubMed ID: 37409661
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease.
Peacock A; Dehle FC; Mesa Zapata OA; Gennari F; Williams MRI; Hamad N; Larsen S; Harrison SJ; Taylor C
J Health Econ Outcomes Res; 2024; 11(1):23-31. PubMed ID: 38312919
[No Abstract] [Full Text] [Related]
3. Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T-cell lymphoma.
Aires D; Abhyankar S
Hematol Oncol; 2023 Dec; 41(5):809-816. PubMed ID: 37974524
[TBL] [Abstract][Full Text] [Related]
4. Mode of action, indications and recommendations on extracorporeal photopheresis (ECP).
Cho A; Paulitschke V; Knobler R
J Dtsch Dermatol Ges; 2023 Nov; 21(11):1369-1380. PubMed ID: 37723908
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal Photopheresis-An Overview.
Cho A; Jantschitsch C; Knobler R
Front Med (Lausanne); 2018; 5():236. PubMed ID: 30211164
[TBL] [Abstract][Full Text] [Related]
6. Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma.
Ninosu N; Melchers S; Kappenstein M; Booken N; Hansen I; Blanchard M; Guenova E; Assaf C; Goerdt S; Nicolay JP
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201568
[TBL] [Abstract][Full Text] [Related]
7. The effect of extracorporeal photopheresis on cytokines released by leukaemic cutaneous T-cell lymphoma.
Br J Dermatol; 2023 Oct; 189(5):e97. PubMed ID: 37879744
[No Abstract] [Full Text] [Related]
8. Outcomes of extracorporeal photopheresis in a diverse cohort of patients with cutaneous T-cell lymphoma: a retrospective study at a tertiary care hospital.
Weiner DM; Kumar P; Varadhan R; Sweren R; Kim N; Rozati S
J Dermatolog Treat; 2024 Dec; 35(1):2312250. PubMed ID: 38331434
[No Abstract] [Full Text] [Related]
9. Health-related quality of life and economic implications of cutaneous T-cell lymphoma.
Semenov YR; Rosenberg AR; Herbosa C; Mehta-Shah N; Musiek AC
Br J Dermatol; 2020 Jan; 182(1):190-196. PubMed ID: 30920642
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of offline extracorporeal photopheresis in cutaneous T-cell lymphomas: A retrospective study.
Moreno-Vílchez C; Muniesa C; González-Barca E; García-Muñoz N; Ortega-Sánchez S; Servitje O
Photodermatol Photoimmunol Photomed; 2023 Nov; 39(6):667-669. PubMed ID: 37465951
[No Abstract] [Full Text] [Related]
11. Evaluation of the Cellular Resistance Process in Treated Cells Via Extracorporeal Photopheresis.
Arjmand B; Rezaei Tavirani M; Jahani Sherafat S; Rezaei M; Farahani M; Rezaei Tavirani M
J Lasers Med Sci; 2023; 14():e46. PubMed ID: 38028865
[No Abstract] [Full Text] [Related]
12. The role of the immune system in cutaneous T-cell lymphoma; an area requiring more investigation.
Pileri A; Pimpinelli N
Br J Dermatol; 2023 Oct; 189(5):504-505. PubMed ID: 37487542
[No Abstract] [Full Text] [Related]
13. Refractory pemphigus vulgaris and high-intensity extracorporeal photopheresis: A case report.
Castillo-Aleman YM; Bencomo-Hernandez AA; Ventura-Carmenate Y; Villegas-Valverde CA; Rivero-Jimenez RA;
Photodermatol Photoimmunol Photomed; 2022 Sep; ():. PubMed ID: 36052754
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal Photopheresis in Dermatological Diseases.
Terhaar H; Saleem M; Yusuf N
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474257
[TBL] [Abstract][Full Text] [Related]
15. International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies.
Campbell BA; Dobos G; Haider Z; Prince HM; Bagot M; Evison F; van der Weyden C; McCormack C; Ram-Wolff C; Miladi M; Scarisbrick JJ
Blood Adv; 2023 Nov; 7(21):6639-6647. PubMed ID: 37648672
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T
Peacock A; Dehle F; Mesa Zapata OA; Prince HM; Gennari F; Taylor C
Value Health; 2022 Jun; 25(6):965-974. PubMed ID: 35667784
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.
Prinz B; Behrens W; Hölzle E; Plewig G
Arch Dermatol Res; 1995; 287(7):621-6. PubMed ID: 8534123
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis: what is it and when should it be used?
Scarisbrick J
Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
